Monte Rosa Therapeutics, Inc. (GLUE) stock
GLUENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3039% above fair value
$9.07+0.00 (0.00%)
Close on Nov 18, 2026Market cap $773.79MP/E –Yield –
Monte Rosa Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Monte Rosa Therapeutics's market cap was $878.68M on Nov 11, 2026, against $999.15M a year earlier. Over the last 5 years it ranged from $155.20M to $2.04B, with a median of $381.41M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $878.68M | -9.3% |
| 2025 | Dec 31, 2025 | $968.87M | +127.5% |
| 2024 | Dec 31, 2024 | $425.96M | +50.6% |
| 2023 | Dec 29, 2023 | $282.87M | -23.2% |
| 2022 | Dec 30, 2022 | $368.12M | -61.2% |
| 2021 | Dec 31, 2021 | $949.20M | – |
See a number that looks wrong?